Biotechnology

Amsterdam, February 12, 2022 – Bile duct cancer, also known as cholangiocarcinoma (CCA), is a rare cancer often diagnosed only at an advanced stage. A comprehensive analysis of diagnostic, prognostic, and therapeutic aspects of over...

Despite the signing of a Memorandum of Understanding on animal biotechnology at the end of the Trump administration between the USDA and the Department of Health and Human Services, animal biotechnology approvals remain stalled....

Tuberculosis (TB) is a disease caused by bacteria called mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a...

The world is a wickedly complex place, especially when people have a need to share limited resources. Herding communities in northern Namibia, for instance, are afflicted by poverty, drought and degraded landscapes. International groups...

Immunotherapy enables a patient’s own immune system to attack disease. This breakthrough therapy is helping some people with hard-to-treat cancer feel better and live longer. However, it may not work for everyone. Now, researchers...

In a recent study posted to bioRxiv* preprint server, researchers found frequent recombination of severe acute respiratory syndrome (SARS)-like coronaviruses (SL-CoVs) with diverse gene pools. Study: Correlated substitutions reveal SARS-like coronaviruses recombine frequently with...

President Joe Biden on Monday invoked the national effort to land a man on the Moon 60 years ago in a speech touting his Cancer Moonshot initiative, which aims to slash cancer death...

Hayley Crawford, PhDApplication ScientistIntegral Molecular Sheila Keating, PhDVice President, ImmunologyGigagen Natalie Anosova, PhDDirector, ImmunologyHead of Preclinical ImmunobiologySanofi Broadcast Date: November 10, 2022Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW The COVID-19 pandemic has...

By Jonathan Smith Immunotherapy is proving a massive draw for investors and big pharma companies alike. These privately-owned immuno-oncology startups have bagged hefty funding rounds in the last two years. For decades, the mainstays of cancer...

Australian researchers have revealed how the bacterium Streptococcus pneumoniae (pneumococcus) obtains the essential nutrient, manganese, from our bodies, which could lead to better therapies to target what is a life-threatening, antibiotic-resistant pathogen. Pneumococcus is...